These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
800 related articles for article (PubMed ID: 28661031)
1. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis. Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031 [TBL] [Abstract][Full Text] [Related]
2. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment. Qu P; Wang LZ; Lin PC Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756 [TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Dysthe M; Parihar R Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608 [TBL] [Abstract][Full Text] [Related]
4. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond. Pastaki Khoshbin A; Eskian M; Keshavarz-Fathi M; Rezaei N Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):89-102. PubMed ID: 30386868 [TBL] [Abstract][Full Text] [Related]
5. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression. Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671 [TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy. Yin Z; Li C; Wang J; Xue L Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569 [TBL] [Abstract][Full Text] [Related]
7. Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression. Zhang J; Han X; Shi H; Gao Y; Qiao X; Li H; Wei M; Zeng X Mol Cell Probes; 2020 Apr; 50():101498. PubMed ID: 31891749 [TBL] [Abstract][Full Text] [Related]
8. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. De Cicco P; Ercolano G; Ianaro A Front Immunol; 2020; 11():1680. PubMed ID: 32849585 [TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives. Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008 [TBL] [Abstract][Full Text] [Related]
10. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
11. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology]. Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197 [TBL] [Abstract][Full Text] [Related]
12. In Brief: Myeloid-derived suppressor cells in cancer. Solito S; Pinton L; Mandruzzato S J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660 [TBL] [Abstract][Full Text] [Related]
13. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression. Chen Z; Yuan R; Hu S; Yuan W; Sun Z Front Immunol; 2022; 13():817942. PubMed ID: 35154134 [TBL] [Abstract][Full Text] [Related]
14. The immunobiology of myeloid-derived suppressor cells in cancer. Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648 [TBL] [Abstract][Full Text] [Related]
15. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis. Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093 [TBL] [Abstract][Full Text] [Related]
16. Role of myeloid-derived suppressor cells in metastasis. Cole K; Pravoverov K; Talmadge JE Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. Parker KH; Beury DW; Ostrand-Rosenberg S Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631 [TBL] [Abstract][Full Text] [Related]
18. MDSCs: The Key Players in the Formation of Pre-Metastatic Niche. Cui W; Wang Z; Lv J; Qin Y; Shi H Front Biosci (Landmark Ed); 2023 Mar; 28(3):58. PubMed ID: 37005751 [TBL] [Abstract][Full Text] [Related]
19. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche. Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937 [TBL] [Abstract][Full Text] [Related]
20. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. Su MT; Kumata S; Endo S; Okada Y; Takai T Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]